These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 411841)
21. Cephalexin in the treatment of upper respiratory tract infections. Disney FA Postgrad Med J; 1983; 59 Suppl 5():28-31. PubMed ID: 6364087 [TBL] [Abstract][Full Text] [Related]
22. [Clinical and laboratory studies on S-6437 (a new longacting granule of cephalexin) in pediatric field (author's transl)]. Kondo K; Kuno K; Koide T; Fukaya K; Jose H Jpn J Antibiot; 1977 Sep; 30(9):691-8. PubMed ID: 916190 [TBL] [Abstract][Full Text] [Related]
26. [Relationship between urinary antimicrobial concentration and MIC--in clinical studies on S-6436 (author's transl)]. Doi T; Kawada Y; Nishiura T Kansenshogaku Zasshi; 1977 Jun; 51(6):327-34. PubMed ID: 411846 [No Abstract] [Full Text] [Related]
27. [Treatment of otorhinolaryngological infections with BB-K8 (author's transl)]. Sambe B; Murakami H; Kobayasi K; Jo K; Inafuku S Jpn J Antibiot; 1974 Jun; 27(3):370-6. PubMed ID: 4215901 [No Abstract] [Full Text] [Related]
28. [Absorption and excretion, and clinical study of sustained release cephalexin (S-6437) in children (author's transl)]. Motohiro T; Sakata Y; Nishiyama T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F Jpn J Antibiot; 1977 Dec; 30(12):961-72. PubMed ID: 340723 [No Abstract] [Full Text] [Related]
29. [Clinical application of clindamycin-2-phosphate to otorhinolaryngological infections (author's transl)]. Baba S; Wada K; Naito M; Hondo J; Fukuoka Y Jpn J Antibiot; 1977 May; 30(5):341-5. PubMed ID: 266632 [No Abstract] [Full Text] [Related]
30. [Clinical study of S-6437 in pediatrics (author's transl)]. Minamitani M; Hachimori K; Nakazawa H Jpn J Antibiot; 1977 Sep; 30(9):677-83. PubMed ID: 916188 [TBL] [Abstract][Full Text] [Related]
31. [Double-blind comparison of cefadroxil and cephalexin granules in the treatment of impetigo]. Arata J; Nohara N; Suwaki M; Umemura S; Nakagawa S; Miyoshi K; Yamamoto Y; Nishihara O; Yamada M; Hiramatsu H Jpn J Antibiot; 1983 Jun; 36(6):1443-60. PubMed ID: 6361311 [TBL] [Abstract][Full Text] [Related]
32. [Clinical studies of S-6436 in the field of obsterics and gynecology (author's transl)]. Matsuda S; Tanno M; Kashiwagura T Kansenshogaku Zasshi; 1977 Jul; 51(7):377-80. PubMed ID: 411853 [No Abstract] [Full Text] [Related]
33. [Clinical experience with sustained release cephalexin (S-6436) in urology (author's transl)]. Konya H; Kuroda J; Iwao N Jpn J Antibiot; 1977 Nov; 30(11):898-905. PubMed ID: 592491 [TBL] [Abstract][Full Text] [Related]
34. [Fundamental and clinical studies on S-6436 (author's transl)]. Nasu M; Nakatomi M; Hirota M; Nagasawa T; Horiuchi N Kansenshogaku Zasshi; 1977 Jul; 51(7):371-6. PubMed ID: 411852 [No Abstract] [Full Text] [Related]
35. Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics. Ginsburg CM; McCracken GH J Pediatr; 1980 Feb; 96(2):340-2. PubMed ID: 7351610 [No Abstract] [Full Text] [Related]
36. [Clinical study of sustained release cephalexin (S-6436, S-6437) in dermatology (author's transl)]. Okita K; Sato M; Hayakawa K; Kimura K Jpn J Antibiot; 1977 Nov; 30(11):911-5. PubMed ID: 592493 [TBL] [Abstract][Full Text] [Related]
37. Three-day and seven-day treatment in acute otitis media: a double-blind antibiotic trial. Jones R; Bain J J R Coll Gen Pract; 1986 Aug; 36(289):356-8. PubMed ID: 3735223 [TBL] [Abstract][Full Text] [Related]